88 results on '"Van Laere, Koen"'
Search Results
2. Novel Targets for Molecular Imaging of Inflammatory Processes of Carotid Atherosclerosis: A Systematic Review
3. Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study
4. Higher diagnostic yield of 18F-FDG PET in inflammation of unknown origin compared to fever of unknown origin
5. Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
6. Evaluating the pharmacodynamic effects of padsevonil in healthy volunteers using simultaneous [11C]-UCB-J PET and MR Arterial Spin Labeling measurements
7. An optimized MRI and PET based clinical protocol for improving the differential diagnosis of geriatric depression and Alzheimer's disease
8. Simplified Edinburgh and modified Boston criteria in relation to amyloid PET for lobar intracerebral hemorrhage
9. Age-related GABAergic differences in the primary sensorimotor cortex: A multimodal approach combining PET, MRS and TMS
10. Approximating anatomically-guided PET reconstruction in image space using a convolutional neural network
11. A new perspective for advanced positron emission tomography–based molecular imaging in neurodegenerative proteinopathies
12. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes
13. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
14. Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia
15. Synaptic density changes following electroconvulsive therapy: A longitudinal pilot study with PET-MR 11C-UCB-J imaging in late-life depression
16. PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide
17. Retention of [18F]fluoride on reversed phase HPLC columns
18. Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors
19. Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice
20. Association of central serotonin transporter availability and body mass index in healthy Europeans
21. In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
22. Lack of endogenous opioid release during sustained visceral pain: A [11C]carfentanil PET study
23. Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
24. Evaluation of [18F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human
25. No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers
26. Binary classification of 18F-flutemetamol PET using machine learning: Comparison with visual reads and structural MRI
27. Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: A positron emission tomography study using [18F]fallypride
28. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging
29. Regional Brain Activity in Functional Dyspepsia: A H 215O-PET Study on the Role of Gastric Sensitivity and Abuse History
30. Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging
31. Long term clinical outcome of peripheral nerve stimulation in patients with chronic peripheral neuropathic pain
32. Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study
33. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [ 18F]MK-9470 PET
34. Labelling and biological evaluation of [ 11C]methoxy-Sch225336: a radioligand for the cannabinoid-type 2 receptor
35. Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [ 18F]FECT
36. The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake
37. Neuronuclear Assessment of Patients With Epilepsy
38. Non-invasive imaging of neuropathology in a rat model of α-synuclein overexpression
39. Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat
40. Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
41. 69. Lower Grey Matter Volume is not Related to Synaptic Density in Late Life Depression
42. Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction
43. Small animal positron emission tomography during vagus nerve stimulation in rats: A pilot study
44. Chasing Map Plasticity in Neuropathic Pain
45. P546. Preclinical Characterization and Phase 1 Evaluation of the Tolerability, Pharmacokinetics, and Enzyme Occupancy of MK-8189, a Novel PDE10A Inhibitor
46. Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo
47. Asymmetric Amyloid Deposition in the Brain Following Unilateral Electroconvulsive Therapy
48. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type
49. Chapter 4 - Cannabinoids and Huntington’s disease
50. APOLIPOPROTEIN E AND BIN1 POLYMORPHISMS DIFFERENTIALLY AFFECT CORTICAL AMYLOID AND TAU LOAD IN HEALTHY OLDER ADULTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.